DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Varespladib is an investigational drug.
There have been 8 clinical trials for Varespladib. The most recent clinical trial was a Phase 2 trial, which was initiated on May 1st 2010.
The most common disease conditions in clinical trials are Syndrome, Anemia, Sickle Cell, and Acute Coronary Syndrome. The leading clinical trial sponsors are Anthera Pharmaceuticals, Shifa Tameer-e-Millat University, and Rawalpindi Institute of Cardiology.
Recent Clinical Trials for Varespladib
|Effect of Colchicine in Patients With Myocardial Infarction||Rawalpindi Institute of Cardiology||Phase 2|
|Effect of Colchicine in Patients With Myocardial Infarction||Shifa Tameer-e-Millat University||Phase 2|
|A Study of Varespladib Infusion in Subjects With Sickle Cell Disease.||Anthera Pharmaceuticals||Phase 2|